Daniel Seiden

1 day ago | news.bloomberglaw.com | Daniel Seiden

The National Institutes of Health’s re-evaluation of bids under a $50 billion IT services procurement called Chief Information Officer–Solutions and Partners 4 is ongoing, but several matters—including President Donald Trump’s executive orders—"complicate” the review, US Department of Justice attorneys said Tuesday.

1 day ago | news.bloombergtax.com | Daniel Seiden

The National Institutes of Health’s re-evaluation of bids under a $50 billion IT services procurement called Chief Information Officer–Solutions and Partners 4 is ongoing, but several matters—including President Donald Trump’s executive orders—"complicate” the review, US Department of Justice attorneys said Tuesday.

2 days ago | news.bloomberglaw.com | Daniel Seiden

Damages won in 2022, but misconduct allegedly continuedEvidence shows higher salaries for non-Black professorsA Black Arizona State University professor can continue with his claims alleging that the school’s salary practices were unlawfully discriminatory under Title VII of the Civil Rights Act, a federal district court said. Nicholas Alozie can advance a portion of claims in his suit filed in 2023, including claims that the school has underpaid him because of his race, Senior Judge Susan R.

2 days ago | news.bloomberglaw.com | Daniel Seiden

A land loader moves logs during a tree harvest on Aug. 27, 2020. Photographer: Ty Wright/Bloomberg via Getty Images May 13, 2025, 4:50 PM UTC Daniel Seiden Senior ReporterThomas Creek Lumber and Log Co. and the US Forest Service have ended their nearly six-year Oregon timber harvesting contract dispute. The parties filed Monday a joint stipulation of dismissal with the US Court of Federal Claims. The case is closed, according to the docket. The US Department of Justice declined to comment.

2 days ago | news.bloomberglaw.com | Daniel Seiden

Report sought on effect to protested prostate drug procurementDaVinci’s protest says Trade Agreements Act should apply The DaVinci Co. and the US government must submit to a federal court a brief discussing whether President Donald Trump‘s new prescription drug executive order will affect a challenged pharmaceutical procurement. The joint status report is due May 16, Judge Loren A. Smith of the US Court of Federal Claims said in a Monday order.